5-MAPDB: 5-MAPDB is a dihydrobenzofuran entactogen first characterized by Monte et al. (1993) and pharmacologically profiled by Rickli et al. (2015). It acts as a relatively selective serotonin releaser (SERT IC50 ≈1.2 μM) with minimal dopamine transporter activity (DAT IC50 ≈77 μM), giving it a hig
Get to know drugs.
Related pages